南平招聘

岗位职责：

¨ Portfolio management

· Support the team in developing the Mid to long term Portfolio Strategic Plan

· Engage in portfolio analysis process to identify market opportunity and formulate forecasting to maximize growth in China by evaluating product, TA and channel potentials

· Maintain and update portfolio/project related documents, tracker and tool for both in-market and pipeline products

¨ Market Intelligence

· To act as the super user of IMS database in local, to support local team regarding to IMS CHPA data maintenance, update and analysis. Provide IMS data analysis for individual product as request

· Competitors’ registration, BE/CT status follow-up, and closely monitor the new approval from key authority such as FDA, EMA, CFDA.

· Provide business analysis support of sales, market share, portfolio transformation and market dynamics per request.

任职要求：

Education : Bachelor degree or above in health related, medical or pharmaceutical science is preferred.

Languages: Excellent oral and written English



Experience



§ At least 3 years working experience in pharmaceutical industry, experience in multinational pharma is desire

§ Experience in sales or marketing analysis, familiar with IMS database is desired

§ Good knowledge of local pharmaceutical industry, knowledge of registration is plus

§ Optimistic and easy going







Key Competencies:



§ Capable skills of Microsoft office is necessary, such as excel and PowerPoint.

§ Business Acumen, knowledgeable in current and possible future policies, practices, trends, technology, and information affecting business

§ Drive for Results, steadfastly pushes self and others for results

§ Time Management, uses time effectively and efficiently & values time;

§ Customer Focus, establishes and maintains effective relationships with customers

北京诺华制药有限公司开发、生产和销售治疗多种疾病的创新处方药，涵盖的疾病领域包括：心血管、内分泌、肿瘤、抗感染、风湿疼痛及骨质疏松、移植免疫、中枢神经以及眼科。北京诺华制药曾获得“***雇主”和“最负社会责任的企业”等殊荣。

“诺华”中文取意“承诺中华”，即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。北京诺华制药成立于1987年，总部设在北京，隶属于瑞士诺华公司。

诺华公司致力于为患者及社会提供创新医药保健解决方案，以满足其日益变化的健康需求。2011年，集团持续经营业务实现净销售586亿美元。集团研发投入约为96亿美元（去除减值及摊销后为92亿美元）。诺华集团总部位于瑞士巴塞尔，业务遍及全球140多个国家和地区，拥有124,000位全职员工。诺华集团立足在中国的长期发展，重要战略投资包括位于上海的综合性生物医学研发中心，以及位于北京昌平的制剂生产工厂和江苏常熟的原料药生产工厂。如需更多信息，敬请登录公司网站http://www.novartis.com和http://www.novartis.com.cn。